Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

CSBR

Champions Oncology Inc

Dec 11 • 09:41AM ET

5.64

Dollar change +0.43
Percentage change 8.25	%

Healthcare • Biotechnology • USA • NASD

Peers: INCY BPMC FATE ZLAB KURA PBYI XENE ONCT MEIP IKT

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.25	Insider Own	56.75%	Shs Outstand	13.59M	Perf Week	31.16%
Market Cap	76.67M	Forward P/E	29.68	EPS next Y	0.19	Insider Trans	0.00%	Shs Float	5.88M	Perf Month	25.06%
Income	-3.40M	PEG	-	EPS next Q	0.01	Inst Own	18.62%	Short Float	3.71%	Perf Quarter	26.46%
Sales	51.65M	P/S	1.48	EPS this Y	128.26%	Inst Trans	-10.79%	Short Ratio	3.92	Perf Half Y	21.29%
Book/sh	-0.02	P/B	-	EPS next Y	46.15%	ROA	-12.39%	Short Interest	0.22M	Perf Year	8.25%
Cash/sh	0.21	P/C	26.53	EPS next 5Y	15.00%	ROE	-432.46%	52W Range	3.60 - 7.13	Perf YTD	0.36%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-60.79%	52W High	-20.90%	Beta	0.46
Dividend TTM	-	Quick Ratio	0.69	Sales past 5Y	13.78%	Gross Margin	44.27%	52W Low	56.66%	ATR (14)	0.38
Dividend Ex-Date	-	Current Ratio	0.69	EPS Y/Y TTM	55.19%	Oper. Margin	-5.88%	RSI (14)	73.90	Volatility	11.32% 8.00%
Employees	210	Debt/Eq	-	Sales Y/Y TTM	-1.96%	Profit Margin	-6.58%	Recom	1.00	Target Price	6.00
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	149.21%	Payout	-	Rel Volume	5.07	Prev Close	5.21
Sales Surprise	6.60%	EPS Surprise	466.67%	Sales Q/Q	11.94%	Earnings	Sep 11 AMC	Avg Volume	55.63K	Price	5.64
SMA20	24.34%	SMA50	27.35%	SMA200	17.42%	Trades		Volume	21,652	Change	8.25%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-12-24	Upgrade	Craig Hallum	Hold → Buy	$6
Nov-18-19	Initiated	The Benchmark Company	Speculative Buy

Dec-05-24 04:30PM	Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024 (ACCESSWIRE) +6.22%
Oct-16-24 10:55AM	Champions Oncology Announces Agreement with Weill Cornell Medicine (ACCESSWIRE)
Oct-09-24 07:00PM	Champions Oncology Inc (CSBR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
03:05PM	Champions Oncology Inc (CSBR) Q4 2024 Earnings Call Highlights: Navigating Challenges and ... (GuruFocus.com)
Sep-12-24 08:03AM	Champions Oncology, Inc. (NASDAQ:CSBR) Q1 2025 Earnings Call Transcript (Insider Monkey) +9.58%
04:00PM	Loading…
Sep-11-24 04:00PM	Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million (ACCESSWIRE)
Sep-09-24 04:00PM	Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024 (ACCESSWIRE) -6.62%
Jul-18-24 09:53PM	CSBR Stock Earnings: Champions Oncology Beats EPS, Beats Revenue for Q4 2024 (InvestorPlace)
04:00PM	Champions Oncology Reports Quarterly Revenue of $14.0 Million (ACCESSWIRE)
Jul-11-24 04:05PM	Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024 (ACCESSWIRE)
Jun-04-24 09:00AM	Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development (ACCESSWIRE)
Mar-19-24 08:28AM	Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2024 Earnings Call Transcript (Insider Monkey)
Mar-12-24 04:30PM	Champions Oncology Reports Quarterly Revenue of $12.0 Million (ACCESSWIRE)
Mar-07-24 09:00AM	Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation (ACCESSWIRE)
Mar-06-24 04:35PM	Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024 (ACCESSWIRE)
08:22AM	Loading…
Dec-14-23 08:22AM	Champions Oncology, Inc. (NASDAQ:CSBR) Q2 2024 Earnings Call Transcript (Insider Monkey)
Dec-12-23 09:54PM	CSBR Stock Earnings: Champions Oncology Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace) -6.49% +5.42%
04:00PM	Champions Oncology Reports Quarterly Revenue of $11.6 Million (ACCESSWIRE)
Dec-04-23 04:30PM	Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023 (ACCESSWIRE)
Nov-02-23 08:30AM	Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification (ACCESSWIRE)
Oct-17-23 08:30AM	Champions Oncology Announces the Addition of Brady Davis as President (ACCESSWIRE)
Sep-13-23 04:00PM	Champions Oncology Reports Quarterly Revenue of $12.6 Million (ACCESSWIRE) -16.29%
Sep-11-23 04:00PM	Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 13, 2023 (ACCESSWIRE)
Aug-22-23 08:30AM	Champions Oncology Announces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023 (ACCESSWIRE)
Aug-01-23 08:45AM	Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies (ACCESSWIRE)
Jul-24-23 04:00PM	Champions Oncology Reports Quarterly Revenue of $13.1 Million (ACCESSWIRE) -8.03%
Jul-20-23 04:00PM	Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023 (ACCESSWIRE)
Apr-17-23 08:30AM	Champions Oncology Announces the Formation of Corellia AI, a Wholly Owned Biotech that Leverages Unique AI-Enabled Workflows for Novel Therapeutic Development (ACCESSWIRE) +8.54%
Apr-05-23 09:50AM	Champions Oncology Announces $5M Stock Repurchase Program (ACCESSWIRE) +5.26%
Mar-15-23 03:50PM	Champions Oncology Reports Quarterly Revenue of $12.8 Million (ACCESSWIRE)
08:30AM	Loading…
Mar-13-23 08:30AM	Champions Oncology to Announce Third Quarter Financial Results on Wednesday, March 15, 2023 (ACCESSWIRE)
Dec-16-22 08:48AM	Champions Oncology, Inc. (NASDAQ:CSBR) Q2 2023 Earnings Call Transcript (Insider Monkey) -10.91%
Dec-13-22 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $14.3 Million (ACCESSWIRE) +5.21% -31.04%
Dec-09-22 04:30PM	Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022 (ACCESSWIRE)
Sep-08-22 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $13.7 Million (ACCESSWIRE)
Sep-06-22 04:00PM	Champions Oncology to Announce First Quarter Financial Results on Thursday, September 8, 2022 (ACCESSWIRE) -5.38%
Aug-15-22 08:08AM	What Type Of Shareholders Make Up Champions Oncology, Inc.'s (NASDAQ:CSBR) Share Registry? (Simply Wall St.)
Jul-23-22 09:57AM	We Ran A Stock Scan For Earnings Growth And Champions Oncology (NASDAQ:CSBR) Passed With Ease (Simply Wall St.)
Jul-21-22 04:00PM	Champions Oncology Reports Quarterly Revenue of $12.9 Million (ACCESSWIRE) +8.12%
Jul-14-22 04:00PM	Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022 (ACCESSWIRE)
Jun-13-22 06:30AM	Investors in Champions Oncology (NASDAQ:CSBR) have made a impressive return of 197% over the past five years (Simply Wall St.)
May-31-22 08:30AM	Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics (ACCESSWIRE)
May-03-22 08:30AM	Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo (ACCESSWIRE)
May-02-22 01:16PM	Champions Oncology, Inc.'s (NASDAQ:CSBR) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong? (Simply Wall St.)
Mar-15-22 04:45PM	Champions Oncology Reports Record Quarterly Revenue of $13.2 Million Reported Adjusted EBITDA of $1.5 million (ACCESSWIRE) +8.17%
Mar-11-22 08:30AM	Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 15, 2022 (ACCESSWIRE)
Mar-07-22 01:10PM	Do Institutions Own Champions Oncology, Inc. (NASDAQ:CSBR) Shares? (Simply Wall St.)
Feb-15-22 08:30AM	Champions Oncology Announces a Partnership with GigaMune to Discover Novel Tumor-Reactive T Cell Receptors (ACCESSWIRE) +6.47%
Jan-20-22 08:30AM	Champions Oncology Announces a Partnership with Fannin Innovation to Jointly Develop Therapeutic Raptamer Drug Conjugates (ACCESSWIRE)
Jan-04-22 08:30AM	Champions Oncology Announces a Partnership with Alloy Therapeutics to Develop Therapeutic Monoclonal Antibodies for Use in ADC Programs (ACCESSWIRE)
05:07AM	Champions Oncology's (NASDAQ:CSBR) investors will be pleased with their impressive 149% return over the last five years (Simply Wall St.)
Dec-13-21 04:20PM	Champions Oncology Reports Record Quarterly Revenue of $11.8 Million (ACCESSWIRE)
Dec-06-21 09:20AM	Champions Oncology to Announce Second Quarter Financial Results on Monday, December 13, 2021 (ACCESSWIRE)
Nov-05-21 08:24AM	Champions Oncology, Inc.'s (NASDAQ:CSBR) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat? (Simply Wall St.)
Oct-20-21 10:25AM	Champions Oncology Expands Global Biomarker Capabilities with Opening of European Laboratory at OpenZone Life Sciences Campus (ACCESSWIRE)
Sep-13-21 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $11.3 Million (ACCESSWIRE)
Sep-06-21 03:00PM	Champions Oncology, Inc. (CSBR) Reports Next Week: What You Should Expect (Zacks)
07:09AM	What Kind Of Shareholders Hold The Majority In Champions Oncology, Inc.'s (NASDAQ:CSBR) Shares? (Simply Wall St.)
Sep-02-21 04:30PM	Champions Oncology to Announce First Quarter Financial Results on Monday, September 13, 2021 (ACCESSWIRE) +5.49%
Jul-26-21 08:30AM	Champions Oncology Announces an Expanded Corporate Strategy to Include Drug Discovery and Development (ACCESSWIRE)
Jul-22-21 08:00AM	Champions Oncology Reports Quarterly Revenue of $10.6 Million (ACCESSWIRE)
Jul-14-21 08:30AM	Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 22, 2021 (ACCESSWIRE)
Jul-08-21 03:06AM	The Champions Oncology (NASDAQ:CSBR) Share Price Is Up 335% And Shareholders Are Delighted (Simply Wall St.)
Jun-15-21 09:00AM	Champions Oncology and BGI Americas Announce a Strategic Partnership to Provide Mass Spectrometry Proteomics, Metabolomics, and Multi-Omic Data Analysis Solutions (ACCESSWIRE)
Apr-29-21 03:31AM	Here's Why We're Not At All Concerned With Champions Oncology's (NASDAQ:CSBR) Cash Burn Situation (Simply Wall St.) +5.34%
Apr-16-21 12:00PM	Champions Oncology, Inc. (CSBR) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Mar-16-21 10:52AM	Strength Seen in Champions Oncology, Inc. (CSBR): Can Its 15.3% Jump Turn into More Strength? (Zacks)
Mar-15-21 02:13AM	What Type Of Shareholders Own The Most Number of Champions Oncology, Inc. (NASDAQ:CSBR) Shares? (Simply Wall St.) +15.31%
Mar-11-21 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $10.8 Million (ACCESSWIRE) +8.09%
02:30PM	Champions Oncology, Inc. to Host Earnings Call (ACCESSWIRE)
Mar-05-21 08:30AM	Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 11, 2021 (ACCESSWIRE)
Mar-04-21 12:30PM	Analysts Estimate Champions Oncology, Inc. (CSBR) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-22-21 09:00AM	Champions Oncology Announces Addition to Board of Directors (ACCESSWIRE)
Jan-29-21 12:24AM	Can You Imagine How Jubilant Champions Oncology's (NASDAQ:CSBR) Shareholders Feel About Its 220% Share Price Gain? (Simply Wall St.)
Jan-19-21 09:00AM	Champions Oncology Announces Partnership with Code Ocean to Expand the Functionality of Lumin Bioinformatics (ACCESSWIRE)
Jan-05-21 08:30AM	Champions Oncology Announces the Expansion of Lumin Bioinformatics: Now Featuring a Highly Valuable Set of Proteomic Data and Analytics (ACCESSWIRE)
Dec-15-20 12:22AM	Are Investors Undervaluing Champions Oncology, Inc. (NASDAQ:CSBR) By 25%? (Simply Wall St.)
Dec-14-20 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $10.1 Million (ACCESSWIRE)
Dec-07-20 04:00PM	Champions Oncology to Announce Second Quarter Financial Results on Monday, December 14, 2020 (ACCESSWIRE) +7.07%
Nov-16-20 04:40PM	Champions Oncology Announces the Launch of Lumin Bioinformatics, Its New Oncology Data-Driven SaaS Program (ACCESSWIRE) +14.94%
Nov-11-20 09:00AM	Champions Oncology Expands Its Immuno-Oncology Research Offering by Launching a Unique Autologous Tumor Infiltrating Lymphocyte Ex Vivo Platform (ACCESSWIRE)
Oct-31-20 10:08AM	Should You Investigate Champions Oncology, Inc. (NASDAQ:CSBR) At US$8.78? (Simply Wall St.)
Sep-16-20 07:27AM	Champions Oncology, Inc. Just Beat Revenue Estimates By 11% (Simply Wall St.)
Sep-14-20 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $9.5 Million (ACCESSWIRE) +9.23%
Sep-08-20 04:30PM	Champions Oncology to Announce First Quarter Financial Results on Monday, September 14, 2020 (ACCESSWIRE) -9.35%
Jul-30-20 07:21AM	Champions Oncology, Inc. Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts (Simply Wall St.)
Jul-27-20 04:01PM	Champions Oncology Reports Quarterly Revenue of $8.8 Million (ACCESSWIRE)
Jul-22-20 08:00AM	Champions Oncology to Announce Fourth Quarter Financial Results on Monday, July 27, 2020 (ACCESSWIRE) +6.75%
Jul-15-20 03:55PM	What Type Of Shareholders Own The Most Number of Champions Oncology, Inc. (NASDAQ:CSBR) Shares? (Simply Wall St.)
Jun-17-20 09:37AM	The Truth About Market Timing - June 17, 2020 (Zacks)
May-27-20 07:05AM	If You Had Bought Champions Oncology (NASDAQ:CSBR) Shares Three Years Ago You'd Have Made 278% (Simply Wall St.)
Apr-28-20 09:50AM	Timing the Market, Is it Possible? - April 28, 2020 (Zacks)
Apr-27-20 07:20AM	Is Champions Oncology, Inc. (NASDAQ:CSBR) A Volatile Stock? (Simply Wall St.)
Mar-28-20 09:23AM	Companies Like Champions Oncology (NASDAQ:CSBR) Can Afford To Invest In Growth (Simply Wall St.)
Mar-16-20 09:35AM	When Does Market Timing Actually Work? - March 16, 2020 (Zacks) -14.49%
Mar-12-20 04:17PM	Champions Oncology Reports Record Quarterly Revenue of $9.0 Million (ACCESSWIRE) -12.71% +36.75%
Mar-10-20 08:30AM	Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2020 (ACCESSWIRE) -6.49%
Feb-26-20 09:32AM	Timing the Market, Is it Possible? - February 26, 2020 (Zacks)
Feb-18-20 05:44AM	Does Champions Oncology, Inc.'s (NASDAQ:CSBR) CEO Pay Reflect Performance? (Simply Wall St.)
Feb-05-20 09:23AM	When Does Market Timing Actually Work? - February 05, 2020 (Zacks)

Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ACKERMAN JOEL	Director	Oct 31 '24	Option Exercise	2.63	105,137	276,289	962,134	Nov 01 09:04 AM
Mendelson Daniel Newman	Director	Jan 12 '24	Buy	6.50	1,000	6,500	198,625	Jan 16 11:45 AM
Mendelson Daniel Newman	Director	Jan 11 '24	Buy	6.27	2,000	12,540	197,625	Jan 12 12:47 PM
Mendelson Daniel Newman	Director	Jan 10 '24	Buy	6.31	2,944	18,577	195,625	Jan 11 10:57 AM
Mendelson Daniel Newman	Director	Jan 09 '24	Buy	6.25	3,000	18,750	192,681	Jan 10 08:57 AM
Mendelson Daniel Newman	Director	Jan 08 '24	Buy	6.15	1,000	6,150	189,681	Jan 09 09:08 AM
Mendelson Daniel Newman	Director	Jan 05 '24	Buy	6.09	2,000	12,180	188,681	Jan 08 03:11 PM
Mendelson Daniel Newman	Director	Jan 04 '24	Buy	6.12	3,000	18,360	186,681	Jan 08 02:54 PM
Mendelson Daniel Newman	Director	Jan 03 '24	Buy	5.83	500	2,915	183,681	Jan 04 01:37 PM
Mendelson Daniel Newman	Director	Dec 21 '23	Buy	4.92	2,500	12,300	183,181	Dec 26 11:48 AM
Mendelson Daniel Newman	Director	Dec 20 '23	Buy	4.82	2,100	10,122	180,681	Dec 21 02:31 PM
Mendelson Daniel Newman	Director	Dec 19 '23	Buy	4.75	5,000	23,750	178,581	Dec 20 09:48 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CSBR

Champions Oncology Inc

Upgrade your FINVIZ experience